Your browser doesn't support javascript.
Apheresis medicine in the era of advanced telehealth technologies: An American Society for Apheresis position paper Part I: Understanding the basic technologies and apheresis medicine practice models.
Linz, Walter; Andrzejewski, Chester; Wu, Ding Wen; Li, Yanhua; Roberts, Timothy; Ipe, Tina; Ricci, Kristin; Knight, Susan; Hodjat, Parsa; Reddy, Ramakrishna L; Hofmann, Jan.
  • Linz W; Department of Pathology and Laboratory Medicine, Baylor Scott and White Central Texas, Temple, Texas, USA.
  • Andrzejewski C; Transfusion and Apheresis Medicine Services, Department of Pathology, Baystate Medical Center, Baystate Health, Springfield, Massachusetts, USA.
  • Wu DW; Department of Pathology and Laboratory Medicine, NYU Langone Hospital-Brooklyn, New York, New York, USA.
  • Li Y; Department of Pathology and Laboratory Medicine, New York University School of Medicine, New York, New York, USA.
  • Roberts T; University of Nebraska Medical Center, Omaha, Nebraska, USA.
  • Ipe T; Department of Pathology and Laboratory Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
  • Ricci K; Department of Hematology & Oncology, Cleveland Clinic, Cleveland, Ohio, USA.
  • Knight S; Versiti, Milwaukee, Wisconsin, USA.
  • Hodjat P; Department of Pathology and Laboratory Medicine, Baylor Scott and White Central Texas, Temple, Texas, USA.
  • Reddy RL; American Red Cross Blood Services, Omaha, Nebraska, USA.
  • Hofmann J; Department of Laboratory Medicine, UCSF School of Medicine, San Francisco, California, USA.
J Clin Apher ; 35(5): 460-468, 2020 Sep.
Article in English | MEDLINE | ID: covidwho-1064369
ABSTRACT
The wide spread availability and use of sophisticated high-speed telecommunication networks coupled with inexpensive and easily accessible computing capacity have catalyzed the creation of new tools and strategies for healthcare delivery. Such tools and strategies are of value to apheresis medicine (AM) practitioners if they improve delivery of patient care, enhance safety during a therapeutic apheresis (TA) intervention, facilitate care access, advance technical capabilities of apheresis devices, and/or elevate quality performance within TA programs. In the past several years, healthcare delivery systems' adoption of telecommunication technologies has been fostered by organizational financial and quality improvement objectives. More recently, adoption of telehealth technologies has been catalyzed by the COVID-19 pandemic as these technologies enhance both patient and provider safety in an era of social distancing. These changes will also influence the delivery of TA services which now can be generally viewed in a tripartite model format comprised of traditional hospital-based fixed site locales, mobile TA operations and lately an evolving telemedicine remote management model now reffered to as telapheresis (TLA). This communication developed by the Public Affairs and Advocacy Committee of the American Society for Apheresis (ASFA) and endorsed by its Board of Directors, reviews and describes various aspects of established and evolving electronic technologies related to TLA and the practice of AM. In subsequent companion publications, additional aspects to TLA will be explored and ASFA's vision of reasonable, regulatory compliant and high-quality TLA practices will be expounded.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Blood Component Removal / Telemedicine / SARS-CoV-2 / COVID-19 Type of study: Observational study Limits: Humans Language: English Journal: J Clin Apher Year: 2020 Document Type: Article Affiliation country: Jca.21814

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Blood Component Removal / Telemedicine / SARS-CoV-2 / COVID-19 Type of study: Observational study Limits: Humans Language: English Journal: J Clin Apher Year: 2020 Document Type: Article Affiliation country: Jca.21814